News

  • Associate Professor Rebecca Lim, 2017 NHMRC Grant success

    NHMRC Fellowship success

    Hudson Institute has had outstanding success in the recent National Health and Medical Research Council (NHMRC) Fellowship and Development Grant announcements.…  Read more

  • Protein key to endometrial cancer spread identified

    Scientists have uncovered a protein that could be responsible for endometrial cancer cells detaching from the womb and implanting elsewhere in the body – but a drug that is in development could help. Endometrial cancer is the most commonly diagnosed gynaecological cancer in Australian women, yet there is no early diagnostic test and limited treatment…  Read more

  • Dr Tracey Edgell from the Endometrial Infertility Research Group at Hudson Institute

    NHMRC grant success – women’s health research

    Federal Minister for Health, The Hon. Greg Hunt MP has announced $18 million in National Health and Medical Research Council (NHMRC) funding for women’s health research.…  Read more

  • Associate Professor Rebecca Lim and Dr Atul Malhotra stand before a premature baby, cradled in a humidicrib at Monash Health

    World-first trial of placental cell treatment helping premature babies

    A world-first therapy, developed at Hudson Institute of Medical Research and Monash University, using cells from the human placenta to repair the damaged lungs of premature babies, is giving hope to families of the most fragile infants like Harry Campbell. The results of a clinical trial at the Monash Children’s Hospital – the culmination of…  Read more

  • Dr Andrew Stephens and Dr Simon at the Hudson Institute of Medical Research

    Ovarian cancer screening test underway for 300 patients

    A clinical trial of a screening test developed by Hudson Institute scientist, Dr Andrew Stephens to detect ovarian cancer in its early stages is about to start in a large group of Victorian and South Australian women, thanks to funding from the Ovarian Cancer Research Foundation (OCRF). About 300 women will be recruited to the…  Read more

  • Turbo-charging chemotherapy for lung cancer

    A naturally occurring hormone could help make chemotherapy much more effective for many Australians with lung cancer, according to new findings from Sydney and Melbourne researchers. And the hormone – known as follistatin – also appears to prevent kidney damage, a serious side effect of chemotherapy. The promising new ‘two birds, one stone’ treatment approach, which was…  Read more

  • Simple ‘sleep hormone’ skin patch could protect at-risk newborns

    A simple, cheap treatment of a skin patch containing a naturally occurring ‘sleep hormone’ could soon help to protect newborn babies from brain damage caused by oxygen deprivation at birth. A recent study, led by PhD student Dr James Aridas and Associate Professor Suzanne Miller in The Ritchie Centre, Hudson Institute of Medical Research, is…  Read more

  • Hudson Institute, SCS PhD students excel in Faculty 3MT Final

    Hudson Institute and School of Clinical Sciences PhD student, Aidan Kashyap has taken out second prize in Monash University’s Faculty of Medicine, Nursing and Health Sciences Three Minute Thesis (3MT) Competition. Aidan’s research is finding therapies to help babies who struggle to breathe in their first moments of life due to underdeveloped lungs, as a…  Read more

  • ‘Needle in a haystack’ of stem cells found – hope for cerebral palsy

    Cells that could be used to repair damage to babies’ brains caused by oxygen starvation during pregnancy or at birth have been identified, bringing hope for the prevention of cerebral palsy. A team of researchers from Hudson Institute of Medical Research and Monash University made the discovery while examining stem cells in umbilical cord blood,…  Read more

  • Hormone replacement therapy could help kidney dialysis patients

    Men undergoing kidney dialysis may have lower testosterone and reproductive hormone levels, providing evidence as to why this group are more prone to bone fractures, a new Hudson Institute of Medical Research study has shown. The study, by Clinical Associate Professor Frances Milat and first author Dr Jasna Aleksova, suggests hormone replacement therapy could be…  Read more

Hudson News

Get the inside view on discoveries and patient stories

Stay connected